Skip to main content

Table 8 Base case cost-effectiveness results [intervention: olanzapine (ODT + SOT)]

From: An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco

Strategy

Total cost (MAD)

Total QALY

ICER (cost/QALY)

Olanzapine (ODT + SOT)

MAD 6140

1.5650

–

Risperidone (ODT + SOT)

MAD 7521

1.5517

− MAD 103,907

Aripiprazole (ODT + SOT)

MAD 7403

1.5456

− MAD 65,047

  1. ODT orally disintegrating tablet (formulation), QALY quality-adjusted life years, SOT standard oral tablet [willingness to pay (WTP) = MAD 250,832.40]